Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Ambalal Sarabhai Enterprises Ltd

NSE: AMBALALSA · BSE: 500009 · Pharmaceuticals & Biotechnology · 15 announcements

Share price
₹40.07
Market cap
₹307.1 Cr
Revenue (annual)
₹202.3 Cr
Net profit (annual)
₹17.80 Cr
P/E (TTM)
22.6×Sector 47.4×
Promoter holding
31.36%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:56 IST BSE
Debt & Borrowing

Ambalal Sarabhai Enterprises Debt & Borrowing

Ambalal Sarabhai Enterprises Ltd submitted its annual disclosure for FY 2025-26 under the SEBI Large Corporate framework. The company reported zero incremental borrowings and no mandatory debt security issuance requirements for the period. It does not face any penalties related to the previous block period.

15:50 IST BSE
Debt & Borrowing

Ambalal Sarabhai Enterprises Debt & Borrowing: ₹4 Cr

Ambalal Sarabhai Enterprises Ltd submitted its initial disclosure confirming it is not classified as a Large Corporate for FY 2026. The company reported outstanding borrowings of ₹4.00 Crore as of March 31, 2026. This regulatory filing complies with SEBI debt-raising framework norms for corporate entities.

Value
₹4.00 Cr